p53 Activation by Small Molecules: Application in Oncology
- 18 June 2005
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (14), 4491-4499
- https://doi.org/10.1021/jm058174k
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- Targeting the p53–MDM2 interaction to treat cancerBritish Journal of Cancer, 2004
- A Nonpeptidic Sulfonamide Inhibits the p53−mdm2 Interaction and Activates p53-Dependent Transcription in mdm2-Overexpressing CellsJournal of Medicinal Chemistry, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines 1 1Edited by A. R. FershtJournal of Molecular Biology, 2000
- p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53Oncogene, 1999
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993